Christopher J LaRocca

9PUBLICATIONS
11CO-AUTHORS
Molecular targetsGene and molecular therapyHealth psychologyLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 27, 2024
Oncolytic Adenovirus for the Targeting of Paclitaxel-Resistant Breast Cancer Stem Cells.

Sacha Robert, Natasha Ivelisse Roman Ortiz, Christopher J LaRocca

|Jul 29, 2023
Viral Shedding in Mice following Intravenous Adenovirus Injection: Impact on Biosafety Classification.

Christopher J LaRocca, Kari L Jacobsen, Kazuho Inoko

|Jan 20, 2023
Breast Cancer and Women Veterans: What Is the Impact of Mental Health on Screening Rates?

Saranya Prathibha, Anders D Westanmo, Jane Yuet Ching Hui

|Sep 26, 2021
Subungual Melanoma: A Single Institution Experience.

Christopher J LaRocca, Lily Lai, Rebecca A Nelson

|Aug 23, 2021
ASO Author Reflections: The Role of Oncolytic Virotherapy in Advanced Gastrointestinal Cancers.

Christopher J LaRocca, Masato Yamamoto

|Jul 29, 2021
Interferon Alpha-Expressing Oncolytic Adenovirus for Treatment of Esophageal Adenocarcinoma.

Christopher J LaRocca, Amanda O Salzwedel, Mizuho Sato-Dahlman

Pageof 2